MediLexicon Logo
MediLexicon Logo
Abbreviations        Abbrev Definitions        Dictionary        ICD Codes        Equipment        Hospitals        Drugs        More..


Company: Neurex
Approval Status: Approved September 1997
Treatment for: hypertension
Areas: Cardiovascular / Cardiology; Diabetes / Endocrinology

| General Information |

General Information

Neurex Corporation received marketing clearance from the U.S. Food and Drug Administration (FDA) for Corlopam. Corlopam is an intervenous treatment for severe high blood pressure. Corlopam is administered in the hospital over a six-hour to 48-hour period to relieve severe hypertensive spikes.

< back to top

Corlopam Drug Information

The Corlopam drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.

MediLexicon International Ltd Logo

Privacy Policy   |    Disclaimer   |    Contact / Feedback

MediLexicon International Ltd
Bexhill-on-Sea, UK
MediLexicon International Ltd © 2004-2016 All rights reserved.